Performance analysis of three commercial kits designed for RNA quantification of HIV-1 group O variants

2021 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Elodie Alessandri-Gradt ◽  
Guillemette Unal ◽  
Adeline Baron ◽  
Marie Leoz ◽  
Marie Gueudin ◽  
...  
Pathogens ◽  
2021 ◽  
Vol 10 (5) ◽  
pp. 526
Author(s):  
Myriam Vaillancourt ◽  
Audrey Hubert ◽  
Caroline Subra ◽  
Julien Boucher ◽  
Wilfried Wenceslas Bazié ◽  
...  

Extracellular vesicles (EVs) and their contents (proteins, lipids, messenger RNA, microRNA, and DNA) are viewed as intercellular signals, cell-transforming agents, and shelters for viruses that allow both diagnostic and therapeutic interventions. EVs circulating in the blood of individuals infected with human immunodeficiency virus (HIV-1) may provide insights into pathogenesis, inflammation, and disease progression. However, distinguishing plasma membrane EVs from exosomes, exomeres, apoptotic bodies, virions, and contaminating proteins remains challenging. We aimed at comparing sucrose and iodixanol density and velocity gradients along with commercial kits as a means of separating EVs from HIV particles and contaminating protein like calprotectin; and thereby evaluating the suitability of current plasma EVs analysis techniques for identifying new biomarkers of HIV-1 immune activation. Multiple analysis have been performed on HIV-1 infected cell lines, plasma from HIV-1 patients, or plasma from HIV-negative individuals spiked with HIV-1. Commercial kits, the differential centrifugation and density or velocity gradients to precipitate and separate HIV, EVs, and proteins such as calprotectin, have been used. EVs, virions, and contaminating proteins were characterized using Western blot, ELISA, RT-PCR, hydrodynamic size measurement, and enzymatic assay. Conversely to iodixanol density or velocity gradient, protein and virions co-sedimented in the same fractions of the sucrose density gradient than AChE-positive EVs. Iodixanol velocity gradient provided the optimal separation of EVs from viruses and free proteins in culture supernatants and plasma samples from a person living with HIV (PLWH) or a control and revealed a new population of large EVs enriched in microRNA miR-155 and mitochondrial DNA. Although EVs and their contents provide helpful information about several key events in HIV-1 pathogenesis, their purification and extensive characterization by velocity gradient must be investigated thoroughly before further use as biomarkers. By revealing a new population of EVs enriched in miR-155 and mitochondrial DNA, this study paves a way to increase our understanding of HIV-1 pathogenesis.


2009 ◽  
Vol 46 ◽  
pp. S27
Author(s):  
T. Oosterlaken ◽  
P. van Deursen ◽  
S. Jurriaans ◽  
V. Ligeon ◽  
L. Bertens ◽  
...  
Keyword(s):  

PLoS ONE ◽  
2009 ◽  
Vol 4 (6) ◽  
pp. e6008 ◽  
Author(s):  
Ronald J. Lubelchek ◽  
Blake Max ◽  
Caroline J. Sandusky ◽  
Bala Hota ◽  
David E. Barker

2000 ◽  
Vol 53 (8) ◽  
pp. 645-a-646
Author(s):  
S. Yoshida
Keyword(s):  

2015 ◽  
Vol 71 ◽  
pp. 76-81 ◽  
Author(s):  
Thomas Mourez ◽  
Constance Delaugerre ◽  
Muriel Vray ◽  
Véronique Lemée ◽  
François Simon ◽  
...  

AIDS ◽  
1999 ◽  
Vol 13 (2) ◽  
pp. 286 ◽  
Author(s):  
F. Damond ◽  
C. Apetrei ◽  
D. Descamps ◽  
F. Brun-Vézinet ◽  
F. Simon
Keyword(s):  

AIDS ◽  
2001 ◽  
Vol 15 (18) ◽  
pp. 2459-2460 ◽  
Author(s):  
Javier Carbone ◽  
Juana Gil ◽  
José M. Benito ◽  
Angeles Muñóz-Fernández ◽  
Eduardo Fernández-Cruz

Sign in / Sign up

Export Citation Format

Share Document